Suppr超能文献

[H2受体激动剂4-甲基组胺对阿糖胞苷对HL-60白血病细胞细胞毒性的负面影响]

[The negative effect of 4-methylhistamine, an H2 receptor agonist, on cytotoxicity of Ara-C for HL-60 leukemia cells].

作者信息

He Q, Xu Y H

机构信息

Research Laboratory of Blood Physiology, Hunan Medical University, Changsha 410078.

出版信息

Hunan Yi Ke Da Xue Xue Bao. 2000 Feb 28;25(1):1-5.

Abstract

OBJECTIVE

To study the effect of 4-methylhistamine on cytotoxicity of Ara-C for HL-60 leukemia cells in vitro.

METHODS

Proliferation of HL-60 cells was determined by semi-solid colony culture and 3H-TdR incorporation. The typical NBT reduction was used to check cell differentiation. Intracellular cAMP and calcium concentration were determined by high pressure liquid chromatography(HPLC) and fluorescence method, respectively.

RESULTS

When HL-60 cells were pretreated with 10(-8) mol.L-1 4-MH for 24 hrs, the cytotoxicity of Ara-C[10(-8)-10(-4)mol.L-1] for HL-60 leukemia cells was significantly decreased both in liquid and semisolid culture. The result of colony counting indicated that the IC50 for HL-60 cells were 1.68 x 10(-6)mol.L-1 with 4-MH pretreatment nad 2.14 x 10(-8)mol.L-1 without 4-MH pretreatment, respectively. Therefore, the potency of Ara-C was reduced nearly 80 times according to IC50 doses. It is interesting that 10(-6)mol.L-1 ranitidine, an antagonist of H2 receptor, can elaborate the negative effect of 4-MH on cytotoxicity of Ara-C for HL-60 cells.

CONCLUSION

The dose of Ara-C should be adequately increased, or Ara-C should be used with H2 receptor antagonist such as ranitidine when treating myeloid leukemia patients.

摘要

目的

研究4-甲基组胺对阿糖胞苷(Ara-C)体外杀伤HL-60白血病细胞细胞毒性的影响。

方法

采用半固体集落培养和3H-TdR掺入法检测HL-60细胞增殖。用经典的NBT还原法检测细胞分化。分别采用高压液相色谱法(HPLC)和荧光法测定细胞内cAMP和钙浓度。

结果

当HL-60细胞用10^(-8)mol·L^(-1) 4-甲基组胺(4-MH)预处理24小时后,阿糖胞苷[10^(-8)-10^(-4)mol·L^(-1)]在液体和半固体培养中对HL-60白血病细胞的细胞毒性均显著降低。集落计数结果表明,经4-MH预处理后HL-60细胞的半数抑制浓度(IC50)为1.68×10^(-6)mol·L^(-1),未经4-MH预处理时为2.14×10^(-8)mol·L^(-1)。因此,根据IC50剂量,阿糖胞苷的效力降低了近80倍。有趣的是,H2受体拮抗剂10^(-6)mol·L^(-1)雷尼替丁可增强4-MH对阿糖胞苷杀伤HL-60细胞细胞毒性的负面影响。

结论

在治疗髓系白血病患者时,应适当增加阿糖胞苷的剂量,或与雷尼替丁等H2受体拮抗剂联合使用阿糖胞苷。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验